✦ LIBER ✦

Selegiline and mortality in Parkinson's disease

✍ Scribed by Dr. C. W. Olanow; S. Fahn; J. W. Langston; J. Godbold

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 489 KB
Volume: 40
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410400605

No coin nor oath required. For personal study only.

✦ Synopsis

Do Other Studies Show Increased Mortality Due to Selegiline?

Other than the UK study, no clinical trial to date has shown an increase in mortality in association with the use of selegiline. In the Sindepar study, a cohort of I01 untreated P D patients participated in a 14-month prospective, randomized, double-blind, placebo-controlled study followed by open-label follow-up [ 171.

📜 SIMILAR VOLUMES

Selegiline and mortality in Parkinson's

Selegiline and mortality in Parkinson's disease: Another view

✍ A. J. Lees; J. Head; Y. Ben Shlomo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB 👁 1 views

Selegiline and lymphocyte superoxide dis

Selegiline and lymphocyte superoxide dismutase activities in Parkinson's disease

✍ John Kushleika; Dr. Harvey Checkoway; James S. Woods; Jai-Dong Moon; Terri Smith 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 1 views

Genetics of Parkinson's disease and park

Genetics of Parkinson's disease and parkinsonism

✍ John Hardy; Huaiban Cai; Mark R. Cookson; Katrina Gwinn-Hardy; Andrew Singleton 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views

Progabide in Parkinson's disease

✍ M. R. Luquin; J. A. Obeso; B. Scatton; A. Lheroux; J. M. Marchtinez Lage 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

Deprenyl in Parkinson's disease

✍ Amos D Korczyn; Puiu Nisipeanu 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 1 views

Glutamate and Parkinson's disease

✍ David A. Greenberg 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB